Risperdal was improperly marketed by Johnson & Johnson

Johnson & Johnson settles a lawsuit over claims that it’s anti-psychotic drug “Risperdal” caused a male plaintiff to grow breast tissue.

Janssen, a unit of Johnson & Johnson, faces 420 lawsuits brought against the company alleging personal injuries caused by Risperdal.  Almost 130 of the 420 lawsuits claim that Risperdal caused young males to grow breast tissue.

Risperdal was approved by the FDA (Food and Drug Administration) for psychotic disorders including schizophrenia in 1993, although the drug has been promoted for non-FDA approved uses as well.

Johnson & Johnson agreed to pay 181 million to resolve claims by  36 states and the District of Columbia over charges of marketing Risperdal for non-FDA approved uses.

In the settlement Janssen and Johnson & Johnson agreed they would no longer promote the drug for non-FDA approved uses.  Although, Janssen did not admit to any wrongdoing as part of the settlement.

If you believe that you or a loved one has suffered injury or death due to a defective or dangerous pharmaceutical, you may have a right to compensation for your injuries.  The Maher Law Firm and Frank Eidson Attorney At Law, would like to help.